Skip to main content
logo
Zelira Therapeutics Limited (ZLDAF)
OTCMKTS · Delayed Price · Currency is USD
0.2223
-0.0203 (-8.37%)
At close: Oct 21, 2025

Zelira Therapeutics Revenue

In the fiscal year ending June 30, 2025, Zelira Therapeutics had annual revenue of 656.00 AUD, down -99.31%. Zelira Therapeutics had revenue of 1.00 in the half year ending June 30, 2025, a decrease of -100.00%.

Revenue
656.00 AUD
Revenue Growth
-99.31%
P/S Ratio
6,347.07
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.73M USD

Revenue Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 2025656.00-94.30K-99.31%
Jun 30, 202494.95K-206.17K-68.47%
Jun 30, 2023301.12K-1.24M-80.45%
Jun 30, 20221.54M877.31K132.26%
Jun 30, 2021663.32K--
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
American Oncology Network1.76B
Veradigm588.02M
Jushi Holdings256.36M
Glass House Brands221.55M
Elite Pharmaceuticals105.45M
Silence Therapeutics27.17M
Nuo Therapeutics1.95M
Northwest Biotherapeutics1.09M
Revenue Rankings

Zelira Therapeutics News

More News